Agonists of toll-like receptor (TLR)2 and TLR4 are unable to modulate platelet activation by adenosine diphosphate and platelet activating factor

scientific article published on 01 October 2005

Agonists of toll-like receptor (TLR)2 and TLR4 are unable to modulate platelet activation by adenosine diphosphate and platelet activating factor is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID16270639

P50authorMoira K B WhyteQ91291745
P2093author name stringIan Sabroe
David J Buttle
Simon B Brown
Robert F Storey
Steven K Dower
Jon R Ward
Heather M Judge
Lynne Bingle
P433issue4
P304page(s)831-838
P577publication date2005-10-01
P1433published inThrombosis and HaemostasisQ15724413
P1476titleAgonists of toll-like receptor (TLR)2 and TLR4 are unable to modulate platelet activation by adenosine diphosphate and platelet activating factor
P478volume94

Reverse relations

cites work (P2860)
Q61883672A central role for monocytes in Toll-like receptor-mediated activation of the vasculature
Q33443707Acetylsalicylic acid differentially limits the activation and expression of cell death markers in human platelets exposed to Staphylococcus aureus strains
Q34491825Aggregation and microparticle production through toll-like receptor 4 activation in platelets from recently menopausal women
Q36881887Brief Exercise Increases Peripheral Blood NK Cell Counts without Immediate Functional Changes, but Impairs their Responses to ex vivo Stimulation
Q91895067Canine platelets express functional Toll-like receptor-4: lipopolysaccharide-triggered platelet activation is dependent on adenosine diphosphate and thromboxane A2 in dogs
Q42133469Differential modulation of cytokine, chemokine and Toll like receptor expression in chickens infected with classical and variant infectious bursal disease virus
Q91657132Effect of ultrapure lipopolysaccharides derived from diverse bacterial species on the modulation of platelet activation
Q38310270Emerging evidence for platelets as immune and inflammatory effector cells
Q36510868Engagement of platelet toll-like receptor 9 by novel endogenous ligands promotes platelet hyperreactivity and thrombosis.
Q33419814Expression and functionality of Toll-like receptor 3 in the megakaryocytic lineage
Q42366210Human platelet interaction with E. coli O111 promotes tissue-factor-dependent procoagulant activity, involving Toll like receptor 4.
Q33433781Hyaluronan Depolymerization by Megakaryocyte Hyaluronidase-2 Is Required for Thrombopoiesis
Q88158903Hyaluronan in inflammatory bowel disease: Cross-linking inflammation and coagulation
Q58577394Impact of Escherichia coli K12 and O18:K1 on human platelets: Differential effects on platelet activation, RNAs and proteins
Q28078773Intercellular Interactions as Regulators of NETosis
Q42248441Lipopolysaccharide is a direct agonist for platelet RNA splicing
Q33384817Lipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation via TLR4/MyD88 and the cGMP-dependent protein kinase pathway
Q37281999Lipopolysaccharide stimulates platelets through an IL-1β autocrine loop
Q92543091Macrophage Depletion Mitigates Platelet Aggregate Formation in Splenic Marginal Zone and Alleviates LPS-Associated Thrombocytopenia in Rats
Q41200749P-Selectin Targeted Dexamethasone-Loaded Lipid Nanoemulsions: A Novel Therapy to Reduce Vascular Inflammation.
Q91971794Platelet Inflammatory Response to Stress
Q41300060Platelet leukocyte aggregates and markers of platelet aggregation, immune activation and disease progression in HIV infected treatment naive asymptomatic individuals
Q37678953Platelet-bacterial interactions.
Q40553193Platelet-borne complement proteins and their role in platelet-bacteria interactions.
Q35124418Platelets and infections - complex interactions with bacteria.
Q37657202Platelets and innate immunity
Q37809184Platelets as Central Mediators of Systemic Inflammatory Responses
Q37081746Platelets as cellular effectors of inflammation in vascular diseases
Q34590168Platelets as immune mediators: Their role in host defense responses and sepsis
Q26739670Platelets in Pulmonary Immune Responses and Inflammatory Lung Diseases
Q39001947Platelets in neutrophil recruitment to sites of inflammation
Q35101184Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum
Q35037420Regulatory effects of TLR2 on megakaryocytic cell function
Q37869814Review of cellular and molecular pathways linking thrombosis and innate immune system during sepsis.
Q59791517Role of Platelets in Leukocyte Recruitment and Resolution of Inflammation
Q33417641Role of platelet TLR4 expression in pathogensis of septic thrombocytopenia.
Q42137745Stimulation of Toll-like receptor 2 in human platelets induces a thromboinflammatory response through activation of phosphoinositide 3-kinase
Q27004467The Inflammatory Role of Platelets via Their TLRs and Siglec Receptors
Q93092336The Role of Human Platelet Preparation for Toll-Like Receptors 2 and 4 Related Platelet Responsiveness
Q33413094The role of calpain-myosin 9-Rab7b pathway in mediating the expression of Toll-like receptor 4 in platelets: a novel mechanism involved in α-granules trafficking
Q37640684The role of inflammation in regulating platelet production and function: Toll-like receptors in platelets and megakaryocytes
Q34765561The septic milieu triggers expression of spliced tissue factor mRNA in human platelets.
Q37869349The thrombotic potential of oral pathogens
Q47147432Toll-Like Receptor 4 Signalling and Its Impact on Platelet Function, Thrombosis, and Haemostasis.
Q36038084Toll-Like Receptor Signalling Is Not Involved in Platelet Response to Streptococcus pneumoniae In Vitro or In Vivo
Q50115928Translational Implications of Platelets as Vascular First Responders
Q37421811Translational mini-review series on immunology of vascular disease: inflammation, infections and Toll-like receptors in cardiovascular disease

Search more.